ATE157001T1 - Verabreichungsvorrichtung von wirkstoffdispersionen mit kontrollierter freisetzung - Google Patents

Verabreichungsvorrichtung von wirkstoffdispersionen mit kontrollierter freisetzung

Info

Publication number
ATE157001T1
ATE157001T1 AT92311716T AT92311716T ATE157001T1 AT E157001 T1 ATE157001 T1 AT E157001T1 AT 92311716 T AT92311716 T AT 92311716T AT 92311716 T AT92311716 T AT 92311716T AT E157001 T1 ATE157001 T1 AT E157001T1
Authority
AT
Austria
Prior art keywords
controlled release
administration device
hydration
release active
gelatinous
Prior art date
Application number
AT92311716T
Other languages
English (en)
Inventor
Gerald S Rork
James D Pipkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE157001T1 publication Critical patent/ATE157001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92311716T 1991-12-27 1992-12-22 Verabreichungsvorrichtung von wirkstoffdispersionen mit kontrollierter freisetzung ATE157001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (1)

Publication Number Publication Date
ATE157001T1 true ATE157001T1 (de) 1997-09-15

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92311716T ATE157001T1 (de) 1991-12-27 1992-12-22 Verabreichungsvorrichtung von wirkstoffdispersionen mit kontrollierter freisetzung

Country Status (26)

Country Link
EP (1) EP0549331B1 (de)
JP (1) JPH089534B2 (de)
KR (1) KR100281609B1 (de)
CN (1) CN1074368A (de)
AT (1) ATE157001T1 (de)
AU (1) AU660057B2 (de)
BG (1) BG61751B1 (de)
CA (1) CA2085871C (de)
CZ (1) CZ284045B6 (de)
DE (1) DE69221711T2 (de)
DK (1) DK0549331T3 (de)
ES (1) ES2106838T3 (de)
FI (1) FI109451B (de)
GR (1) GR3024885T3 (de)
HU (1) HU219594B (de)
IL (1) IL104189A (de)
LV (1) LV12082B (de)
MX (1) MX9207541A (de)
NO (1) NO310672B1 (de)
NZ (1) NZ245514A (de)
PL (1) PL171110B1 (de)
RO (1) RO112810B1 (de)
RU (1) RU2127586C1 (de)
SK (1) SK279964B6 (de)
WO (1) WO1993012765A1 (de)
YU (1) YU48762B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
CZ297098B6 (cs) * 1997-01-14 2006-09-13 Lts Lohmann Therapie-Systeme Gmbh Prípravek pro kontrolované uvolnování úcinných látek v gastrointestinálním traktu a zpusob jeho výroby
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
EP1183010A2 (de) * 1999-06-04 2002-03-06 ALZA Corporation Implantierbare gel zusammensetzung und verfahren zur herstellung
CA2417764C (en) * 2000-08-08 2009-05-05 Katsuo Kataoka Highly absorbable solid preparations containing sitafloxacin and tartaric acid
RU2165251C1 (ru) * 2000-09-06 2001-04-20 Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко Твердая лекарственная форма эналаприла и способ ее получения
EP1738751B1 (de) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd System zur beabstandeten Abgabe von Arzneimitteln
RU2179022C1 (ru) * 2001-04-19 2002-02-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая противоязвенная композиция и способ ее получения
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
JP4615862B2 (ja) * 2001-12-18 2011-01-19 ノボ・ノルデイスク・エー／エス 固形投与マイクロインプラント
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
TWI353854B (en) * 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
EP1545452A1 (de) * 2002-09-28 2005-06-29 McNEIL-PPC, INC. Dosierungsformen mit modifizierter freisetzung
RU2225200C1 (ru) * 2002-12-23 2004-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Поликом" Фармацевтический состав с противогерпесной активностью и способ лечения вирусной инфекции
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
WO2006014434A2 (en) 2004-07-02 2006-02-09 Eliot Lazar Treatment medium delivery device and methods for delivery
MX2008012601A (es) 2006-03-31 2009-02-10 Qlt Plug Delivery Inc Metodos de suministro de farmaco, estructuras, y composiciones para un sistema nasolagrimal.
WO2009035571A2 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Lacrimal implant detection
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
CA2846384C (en) 2011-08-29 2020-12-15 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
JP7626361B2 (ja) 2018-10-25 2025-02-07 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
DE69221711D1 (de) 1997-09-25
IL104189A (en) 1996-10-31
BG61751B1 (bg) 1998-05-29
KR940703653A (ko) 1994-12-12
FI109451B (fi) 2002-08-15
PL171110B1 (pl) 1997-03-28
FI943011L (fi) 1994-06-22
YU111292A (sh) 1995-12-04
CA2085871A1 (en) 1993-06-28
ES2106838T3 (es) 1997-11-16
MX9207541A (es) 1994-06-30
NZ245514A (en) 1994-12-22
RU94031474A (ru) 1997-04-20
JPH05255071A (ja) 1993-10-05
YU48762B (sh) 1999-11-22
CA2085871C (en) 2002-05-07
GR3024885T3 (en) 1998-01-30
DK0549331T3 (da) 1997-09-15
CZ157094A3 (en) 1994-12-15
KR100281609B1 (ko) 2001-02-15
BG98805A (bg) 1995-03-31
EP0549331A1 (de) 1993-06-30
RO112810B1 (ro) 1998-01-30
CN1074368A (zh) 1993-07-21
HU219594B (hu) 2001-05-28
IL104189A0 (en) 1993-05-13
LV12082B (en) 1998-09-20
HUT70437A (en) 1995-10-30
CZ284045B6 (cs) 1998-07-15
LV12082A (lv) 1998-07-20
SK76994A3 (en) 1995-05-10
AU3034892A (en) 1993-08-12
NO942430D0 (no) 1994-06-27
JPH089534B2 (ja) 1996-01-31
RU2127586C1 (ru) 1999-03-20
EP0549331B1 (de) 1997-08-20
AU660057B2 (en) 1995-06-08
DE69221711T2 (de) 1998-03-12
HU9401913D0 (en) 1994-09-28
SK279964B6 (sk) 1999-06-11
NO310672B1 (no) 2001-08-13
WO1993012765A1 (en) 1993-07-08
NO942430L (no) 1994-06-27
FI943011A0 (fi) 1994-06-22

Similar Documents

Publication Publication Date Title
ATE157001T1 (de) Verabreichungsvorrichtung von wirkstoffdispersionen mit kontrollierter freisetzung
EP0801560A4 (de) Verabreichungssystem mit gesteuerter freisetzung einer arzneistoffsuspension
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
CA2111085A1 (en) Extended-Release Form of Diltiazem
DK0494943T3 (da) Interaktivt system til anvendelse ved lokalt indgreb inde i en ikke homogen struktur
TW347421B (en) Method for enhancing efficacy of fabric to repel insects and fabric for use in manufacture of washable garments
DE59505047D1 (de) Versprühbare filmbildende wirkstoffabgabesysteme zur anwendung an pflanzen
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
DE59505328D1 (de) Transdermales system
DE69322286D1 (de) Verabreichungsvorrichtungen mit gestützten flüssigen membranen
DK0391342T3 (da) Spraygelbasis og spraygel, fremstilling og anvendelse deraf
GB9112267D0 (en) Polymeric coating
ATE221773T1 (de) Formulierungen mit gesteuerter freisetzung
AU3691189A (en) Tablet formulations of pesticides
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
NO922282D0 (no) Formulering for vedvarende frigivelse av acetazolamid, samt fremgangsmaate for fremstilling av formuleringen
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee